Parameter,NNRTI study (efavirenz to rilpivirine),INSTI study (raltegravir to dolutegravir),INSTI study (raltegravir to dolutegravir)
Parameter,NNRTI study (efavirenz to rilpivirine),Control arm,Switch arm
Number,10,8,12
"Age, years median (IQR)",52 (14),39.5 (15.5),43 (13)
"Male, n (%)",10 (100),7 (87.5),12 (100)
"White ethnicity, n (%)",10 (100),5 (62.5),9 (69.2)
"CD4+ count at study entry (cells/μL), median (IQR)",600 (256),688 (395),736 (237)
"HIV RNA viral load < 40 copies/mL, n (%)",10 (100),8 (100),12 (100)
